Skip to main navigation Skip to search Skip to main content

Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients

  • Fadhel A. Alomar*
  • , Marai N. Alshakhs
  • , Salah Abohelaika
  • , Hassan M. Almarzouk
  • , Mohammed Almualim
  • , Amein K. Al-Ali
  • , Fahad Al-Muhanna
  • , Mohammed F. Alomar
  • , Mousa J. Alhaddad
  • , Mohammed S. Almulaify
  • , Faisal S. Alessa
  • , Ahmed S. Alsalman
  • , Ahmed Alaswad
  • , Sean R. Bidasee
  • , Hassan A. Alsaad
  • , Rudaynah A. Alali
  • , Mona H. AlSheikh
  • , Mohammed S. Akhtar
  • , Mohammed Al Mohaini
  • , Abdulkhaliq J. Alsalman
    • Hussain Alturaifi, Keshore R. Bidasee*
*Corresponding author for this work
  • Ministry of Health, Saudi Arabia
  • Qatif Central Hospital
  • Imam Abdulrahman Bin Faisal University
  • University of Nebraska Medical Center
  • King Saud bin Abdulaziz University for Health Sciences
  • Northern Borders University
  • King Fahad Hofuf Hospital

Research output: Contribution to journal › Article › peer-review

5   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology